Respicardia, Inc. Pivotal Trial of the remedē System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT01816776
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 151 participants
- Sponsor
- Respicardia, Inc.
- Registry
-
NCT01816776
-
- Other papers using this trial's data
- Automatic activation of neurostimulation for central sleep apnea results in high nightly usage
- Changes in quality of life in patients with atrial fibrillation and central sleep apnea treated with transvenous phrenic nerve stimulation
- Classifying hypopneas as obstructive or central can enhance transvenous phrenic nerve stimulation therapy patient selection and outcomes
- Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
- Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatment
- Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01816776. Randomized; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2016-09-10 (actual). Results posted on 2017-07-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Respicardia, Inc. Pivotal Trial of the remedē System
- Condition
- Sleep Apnea, Central
- Condition
- Sleep Disordered Breathing
- Condition
- Heart Failure
- Intervention (Device)
- Treatment Group (transvenous stimulation of the phrenic nerve)
- Intervention (Device)
- Control Group (Optimal Medical Therapy)
- Lead sponsor
- Respicardia, Inc.
Record details
- Record id
cardio:ct-nct01816776- Content hash
e7f7bd196e99ea8ed6923587b0239c445eec35751435e6c2a63fa54eb59d5c67